Source link : https://newshealth.biz/health-news/fda-expands-approval-of-chemo-free-bladder-cancer-combo-in-curative-setting/
The FDA approved pembrolizumab (Keytruda) or pembrolizumab and berahyaluronidase alfa (Keytruda Qlex) in combination with enfortumab vedotin (Padcev) as perioperative treatment for adults with muscle-invasive bladder cancer (MIBC), regardless of cisplatin eligibility. This extends the prior approval for the regimen in this setting from patients who are cisplatin-ineligible to all patients with MIBC who are […]
The post FDA Expands Approval of Chemo-Free Bladder Cancer Combo in Curative Setting first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-10 19:03:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8